NASDAQ: NLTX       Neoleukin Therapeutics Inc
Last Price Today's Change   Day's Range   Trading Volume
10.84   0.00 (0.00%)  0.00 - 0.00  0


Avg Volume (4 weeks):182,915
4 Weeks Range:10.474 - 13.915
4 Weeks Price Volatility (%):
52 Weeks Range:2.789 - 18.13
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Nile Therapeutics, Inc. (Nile) is a development-stage biopharmaceutical company in the business of commercially developing products for the treatment of cardiovascular diseases. The Company's product CD-NP, a chimeric natriuretic peptide is in Phase II clinical studies for the treatment of heart failure. The Company is developing CD-NP for an initial indication of acute decompensated heart failure (ADHF). The Company is also developing CU-NP, a pre-clinical rationally designed natriuretic peptide that consists of amino acid chains identical to those produced by the human body, specifically the ring structure of C-type natriuretic peptide (CNP), and the N- and C-termini of Urodilatin (URO).

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor


Top 10 Active Counters
 KSMT 9.5930.00 
 HIPS 11.490.00 
 HONE 9.420.00 
 ENZL 60.480.00 
 KOD 99.760.00 
 UPRO 52.850.00 
 COLD 36.140.00 
 ALYA 2.430.00 
 CIGI 71.850.00 
 AXNX 48.870.00